Monographie - Pentamidine isetionate - Stabilis 4.0

Son güncelleme :
29/10/2024

Antibiyotik

Pentamidine isetionate

Enjeksiyon

Çözeltilerin stabilitesi

Karışımlardaki stabilitesi

Stabiliteyi etkileyen faktörler

Uyumluluk

Uygulama yöntemi

Kaynaklar

pdf

Kimyasal yapı

Ticari isim

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

DBL Pentamidine isetionate	Malezya
Manicare	Arjantin
Nebupent	Amerika Birleşik Devletleri
Pentacarinat	Almanya, Avusturya, Belçika, Büyük Britanya, Danimarka, Finlandiya, Fransa, Hollanda, İspanya, İsveç, İsviçre, İtalya, Kolombiya, Lüksemburg, yeni Zelanda, Yunanistan
Pentam	Amerika Birleşik Devletleri
Pentamidina	Arjantin, İspanya
Pentamidine isethionate	Amerika Birleşik Devletleri, Avustralya, Kanada, Malezya
Pentamina	Portekiz

Kaynaklar

Enjeksiyon

Kaynaklar : Pentamidine isetionate

	tip	yayın
36	Dergi	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Dergi	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Dergi	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Dergi	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Dergi	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Dergi	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Dergi	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Laboratuar	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Dergi	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Dergi	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Dergi	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Dergi	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Laboratuar	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Laboratuar	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Laboratuar	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Laboratuar	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales